Textile Chemistry

As one of the four core businesses of Hongda Group, ......

Material Chemistry

Since 2001,Hongda Group has been a distinctive char ......

Biological Pharmacy

Companies in the bio pharmaceutical development alw ......

Resin & Additive

The company's business covers the development o ......

MEP invest 354 million to supervise pollutant,the pharmacy part is focus

2014.02.17   08:44

         The ministry of Environmental Protection issued the "the second batch of the central government special funds for major pollutants emission reduction projects program in 2013" on December 24,which pointed that in 2013 the total national focus on pollution control four major pollutants supervisory monitoring operating funds of 3.54 billion yuan,2014 is expected to continue to increase the relevant pollutant monitoring budget.
         Recently,the relevant departments issued many policy on the environmental protection.Not only there is the "twelve-five plan",but also has a corresponding areas of production rules introduced for the specific implementation of the industrial sector to make a detailed breakdown of the requirements.For example,in the pharmaceutical industry category,MEP,on the introduction of the pharmaceutical sector and other large and small,fewer than a dozen of the notification,rules,standards and planning.Today,the latest "plan" one,indicating that the Ministry of Environmental Protection pollutant monitoring,management and control of the firm attitude and determination.
         The reason why so many of the pharmaceutical sector the introduction of standards and rules,because in all industrial sectors,the pharmaceutical industry is one of the chemical oxygen demand,ammonia nitrogen emissions from large key industries.In recent years,major pharmaceutical companies increasing emphasis on the ability of the company to improve energy efficiency in pollution control and sustainable development.
         In today's ever-increasing environmental standards,environmental technology has undoubtedly become one of the core competitiveness of enterprise development.Currently,the bulk drugs industry is undergoing industrial restructuring,transformation and upgrading,new GMP certification has eliminated some capacity by improving quality standards.Future environmental protection will also be the elimination of backward production capacity,a major force behind industrial upgrading.

By Ann

Previous:The pharmaceutical industry to rewrite